Target Name: ICAM5
NCBI ID: G7087
Review Report on ICAM5 Target / Biomarker Content of Review Report on ICAM5 Target / Biomarker
ICAM5
Other Name(s): Intercellular adhesion molecule 5 | intercellular adhesion molecule 5 | intercellular adhesion molecule 5, telencephalin | TLN | telencephalin | ICAM-5 | TLCN | ICAM5_HUMAN | Telencephalin

ICAM5: Key Protein in Cell-Cell Adhesion and Tissue Regeneration

ICAM5, also known as Intercellular adhesion molecule 5, is a protein that plays a crucial role in cell-cell adhesion and tissue regeneration. It is a member of the intercellular adhesion molecule (ICAM) family, which consists of six transmembrane proteins that are involved in cell-cell and cell-extracellular matrix (ECM) interactions. ICAM5 is expressed in a wide range of tissues and cells, including epithelial, muscle, and neural cells.

The Importance of ICAM5 in Cell-Cell Adhesion

ICAM5 is a key protein in cell-cell adhesion, as it helps to maintain the integrity of the intercellular space (ICIS) and is involved in the formation of tight junctions (TJs) and adherens junctions (AJs), which are essential for the proper functioning of epithelial tissues. tight junctions and adherens junctions are specialized structures that mediate the transfer of electrical and chemical signals between adjacent cells, and are critical for maintaining tissue structure and function.

ICAM5 is involved in the formation of TJs by interacting with the protein transmembrane protein E-cadherin. This interaction between ICAM5 and E-cadherin is critical for the formation of stable TJs, as TJs are essential for the proper exchange of nutrients, waste products, and other substances between cells.

ICAM5 is also involved in the formation of AJs, which are similar to TJs but are found in different types of cells. AJs are involved in the transfer of mechanical forces between cells and help to maintain the integrity of tissues.

ICAM5 as a Drug Target

ICAM5 has been identified as a potential drug target due to its involvement in cell-cell adhesion. Many studies have shown that ICAM5 is involved in the regulation of cell-cell adhesion, and that it plays a role in the development of various diseases, including cancer.

One of the main advantages of ICAM5 as a drug target is its widespread expression in many different types of cells. This makes it an attractive target for drugs that are designed to inhibit cell-cell adhesion, as such drugs can be administered to a wide range of patients without the need for specific cell types to be targeted.

Another advantage of ICAM5 as a drug target is its involvement in several key processes that are involved in the development and progression of many diseases, including cancer. For example, ICAM5 has been shown to be involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed to supply oxygen and nutrients to tissues.

ICAM5 has also been shown to be involved in the regulation of cell signaling, as well as in the regulation of cellular processes such as cell division and the transport of nutrients and waste products.

ICAM5 as a Biomarker

ICAM5 has also been shown to be involved in several key biological processes that are important for the health and function of many different types of cells. For example, ICAM5 has been shown to be involved in the regulation of cell apoptosis, which is the process by which cells die when they are no longer needed.

ICAM5 has also been shown to be involved in the regulation of cellular signaling, as well as in the regulation of cellular processes such as cell division and the transport of nutrients and waste products.

Conclusion

ICAM5 is a protein that plays a crucial role in cell-cell adhesion and tissue regeneration. It is a member of the ICAM family and is expressed in a wide range of tissues and cells. ICAM5 has been identified as a potential drug target due to its involvement in cell-cell adhesion and its involvement in several key biological processes that are important for the health and function of many different types of cells. Further research is needed to fully understand the role of ICAM5 in

Protein Name: Intercellular Adhesion Molecule 5

Functions: ICAM proteins are ligands for the leukocyte adhesion protein LFA-1 (integrin alpha-L/beta-2)

The "ICAM5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ICAM5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ICE1 | ICE2 | ICMT | ICMT-DT | ICOS | ICOSLG | ID1 | ID2 | ID2-AS1 | ID2B | ID3 | ID4 | IDE | IDH1 | IDH1-AS1 | IDH2 | IDH2-DT | IDH3A | IDH3B | IDH3G | IDI1 | IDI2 | IDI2-AS1 | IDNK | IDO1 | IDO2 | IDS | IDSP1 | IDUA | IER2 | IER3 | IER3-AS1 | IER3IP1 | IER5 | IER5L | IER5L-AS1 | IFFO1 | IFFO2 | IFI16 | IFI27 | IFI27L1 | IFI27L2 | IFI30 | IFI35 | IFI44 | IFI44L | IFI6 | IFIH1 | IFIT1 | IFIT1B | IFIT2 | IFIT3 | IFIT5 | IFITM1 | IFITM10 | IFITM2 | IFITM3 | IFITM3P2 | IFITM3P7 | IFITM4P | IFITM5 | IFITM8P | IFITM9P | IFNA1 | IFNA10 | IFNA12P | IFNA13 | IFNA14 | IFNA16 | IFNA17 | IFNA2 | IFNA21 | IFNA22P | IFNA4 | IFNA5 | IFNA6 | IFNA7 | IFNA8 | IFNAR1 | IFNAR2 | IFNB1 | IFNE | IFNG | IFNG-AS1 | IFNGR1 | IFNGR2 | IFNK | IFNL1 | IFNL2 | IFNL3 | IFNL4 | IFNLR1 | IFNW1 | IFNWP15 | IFNWP19 | IFRD1 | IFRD2 | IFT122 | IFT122P3 | IFT140